Mercado de tratamiento del estreñimiento: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00005408
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 175
Buy Now

[Informe de investigación]Se espera que el mercado de tratamiento del estreñimiento alcance los 13.386,19 millones de dólares en 2027 desde los 8.533,89 millones de dólares de 2019. Se estima que el mercado crecerá con una tasa compuesta anual del 5,9% entre 2020 y 2027.

 
El estreñimiento es un trastorno crónico que provoca evacuaciones intestinales indiferentes y generalmente conduce a heces endurecidas que persisten durante varias semanas o incluso más. Esto suele ocurrir cuando el colon ha absorbido un exceso de agua de los alimentos que se encuentran en el colon.


El informe ofrece información y un análisis en profundidad del mercado del tratamiento del estreñimiento, haciendo hincapié en varios parámetros, como Tendencias del mercado, avances tecnológicos, dinámica del mercado y análisis del panorama competitivo de los principales actores del mercado global. El mercado se ha segmentado según la terapéutica, la enfermedad, el canal de distribución y la región. Según la región, el mercado está segmentado en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central.

Regiones lucrativas para el mercado del tratamiento del estreñimiento

Perspectivas del mercado

Prevalencia creciente del estreñimiento crónico< /p>

El estreñimiento es una condición de salud común entre todos los grupos de edad en todo el mundo. Según el artículo "Estreñimiento crónico" publicado en mayo de 2018, a nivel mundial, se estima que la prevalencia del estreñimiento es del 16%. Se estima que varía entre el 0,7% y el 79%. Además, la prevalencia del estreñimiento es mayor entre las personas de 60 años o más. La prevalencia atribuida de estreñimiento a este grupo de edad es del 33,5 %.

Varios factores están asociados con la creciente prevalencia entre las personas mayores, que incluyen la falta de deposiciones normales debido a edad progresiva, dieta e ingesta de líquidos inadecuadas y actividad física inadecuada. Mientras que, entre los adultos, la causa común del estreñimiento es el estrés, la falta de ejercicio, los trastornos endocrinos, las enfermedades del colon, la disfunción neurológica y otras causas como las condiciones ambientales y farmacéuticas.

< p>La prevalencia del estreñimiento en todo el mundo varía sustancialmente debido a los diferentes grupos étnicos y percepciones. Por ejemplo, según el artículo "¿Cuál es la prevalencia mundial del estreñimiento?" publicado en marzo de 2020, en América del Norte, ~63 millones de personas se ven afectadas por estreñimiento crónico. Asimismo, aproximadamente el 12 % de las personas en todo el mundo viven con estreñimiento autodefinido. Los datos también indicaron que en América y Asia Pacífico la prevalencia es el doble que en la región europea. El estreñimiento causa morbilidad psicológica y resulta en una baja calidad de vida. Por lo tanto, es muy importante diagnosticar, controlar y tratar el estreñimiento. Por lo tanto, se espera que la creciente prevalencia del estreñimiento impulse la demanda de medicamentos para tratar el estreñimiento y conduzca aún más al crecimiento del mercado.

Información basada en terapéutica

Basado en la terapéutica, el mercado del tratamiento del estreñimiento se segmenta en laxantes, activadores de los canales de cloro, antagonistas de los receptores opioides mu de acción periférica, agonistas de GC-C y agonistas del receptor 5-HT4. El segmento de laxantes tuvo la mayor participación de mercado en 2019. Sin embargo, se prevé que el segmento de agonistas de GC-C registre la CAGR más alta del mercado durante el período de pronóstico.

Mercado de tratamiento del estreñimiento, por tratamiento terapéutico: 2019 y 2027

Disease Insights

Basado en la enfermedad, el mercado del tratamiento del estreñimiento se segmenta en estreñimiento crónico idiopático, irritable síndrome intestinal con estreñimiento y estreñimiento inducido por opioides. El segmento de estreñimiento idiopático crónico tuvo la mayor participación del mercado en 2019 y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.

Información del canal de distribución

Según el canal de distribución, el mercado del tratamiento del estreñimiento se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias en línea. El segmento de farmacias minoristas tuvo la mayor participación del mercado en 2019 y se estima que registrará la CAGR más alta del mercado del 6,4% durante el período de pronóstico.

Estratégico Insights

Las empresas suelen adoptar estrategias inorgánicas como asociaciones, fusiones y adquisiciones para satisfacer la cambiante demanda de los clientes en todo el mundo, lo que también les permite mantener su marca. Los actores del mercado del tratamiento del estreñimiento han estado adoptando estrategias orgánicas, como lanzamientos y expansiones de productos, para ampliar su presencia y carteras de productos.

Por Therapeutic

    < li>Laxantes
  • Activadores de canales de cloruro
  • Antagonistas de los receptores opioides mu de acción periférica
  • Agonistas de GC-C
  • Agonistas de los receptores 5-HT4

Por enfermedad

  • Estreñimiento idiopático crónico
  • Síndrome del intestino irritable con estreñimiento
  • Estreñimiento inducido por opioides

Por canal de distribución

  • Farmacias hospitalarias
  • Farmacias minoristas
  • Farmacias en línea

Por geografía

  • América del Norte
    • EE.UU.
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India< /li>
    • Corea del Sur
    • Japón
    • Australia
  • Oriente Medio y África (MEA)
      < li>Sudáfrica
    • Arabia Saudita
    • EAU
  • América del Sur y Central (SCAM)
    • Brasil
    • Argentina

Perfiles de empresas

  • AbbVie's Inc
  • Takeda Pharmaceutical Company Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Mallinckrodt Plc
  • Abbott< /li>
  • Cosmo Pharma
  • Sanofi
  • Albireo Pharma, Inc,
  • AstraZeneca
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is a constipation treatment?

Constipation is a chronic disorder that leads to indifferent bowel movements, usually leading to hardened faeces that persist for several weeks or even longer. This usually happens when the colon absorbs excessive water from the colon food.

What are the driving factors for the constipation treatment market across the globe?

Key factors that are driving growth of the market are increasing research and development for the development of new drugs, improving healthcare infrastructure in various emerging economies, increasing awareness among end-users, growing geriatric population, increasing fast-food consumption and unhealthy lifestyle.

At what cost the drugs are available to treat constipation?

The product's cost varies depending upon the type of drugs, such as branded (innovative) or generic and form such as tablets, syrup, and powder. The price of products also varies depending upon the countries. For instance, the cost of Amitiza oral capsule 8 mg is the ~ US $397 for 60 capsules in the US. Whereas the price for laxative is different from the tablet, for instance, MOVICOL 1 sachet is US$ 0.80 (83.90 yen) in Japan. Similarly, the price of Dulcolax Laxative Tablets for 50 tablets is nearly US$ 6, whereas it cost US$ 0.94 (0.80 €) for one tablet.

The List of Companies - Constipation Treatment Market

  1. AbbVie Inc.
  2. Takeda Pharmaceutical Company Limited
  3. Bausch Health
  4. Bayer AG
  5. Mallinckrodt
  6. Abbott
  7. COSMO PHARMACEUTICALS
  8. Sanofi
  9. Albireo Pharma, Inc
  10. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports